NASDAQ$BIOLQ
Biolase Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
BIOLQ Q2 2024 — $11.6M revenue, 30.00 EPS
The Company’s laser systems are designed to provide clinically superior results for many types of dental procedures compared to those achieved with drills, scalpels, and other con. Biolase Inc reported Q2 2024 results. Diluted EPS came in at $30.00. Net income of $20.6M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $11.6M.
- Diluted EPS: $30.00.
- Net income: $20.6M.
- Operating income: $3K.
- Gross profit: $5K.
Headline financials
Revenue & EPS history
Biolase · Revenue · Quarterly
$11.6M
Revenue by segment
Biolase · $6.7M total across 2 segments · Q3 2023
- US Laser Revenue$3.8M-17.4%56.7%
- International Laser Revenue$2.9M—43.3%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
-3.0%
Avg return
Earnings day
-6.6%
Avg return
5 days after
-13.5%
Avg return
30 days after
41%
24 / 58 earnings
Positive
+25.4%
Q2 2021
Best reaction
-45.7%
Q1 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2024 | -18.9% | -9.9% | +26.1% | |
| Q2 2024 | +7.8% | -10.0% | -30.0% | |
| Q1 2024 | +1.8% | -10.8% | -21.9% | |
| Q4 2024 | +20.3% | +7.5% | -6.8% | |
| Q3 2023 | -22.0% | -17.3% | -23.4% | |
| Q2 2023 | -19.5% | -6.2% | -50.2% | |
| Q1 2023 | -6.7% | -15.4% | -17.4% | |
| Q4 2022 | -10.8% | -24.8% | -43.8% | |
| Q3 2022 | +16.3% | +27.7% | -49.2% | |
| Q2 2022 | -1.1% | -5.3% | -33.6% | |
| Q1 2022 | +0.0% | -2.0% | -47.1% | |
| Q4 2021 | +2.9% | +4.1% | -9.3% | |
| Q3 2021 | -8.2% | -17.9% | -34.5% | |
| Q2 2021 | +25.4% | +5.7% | +10.0% | |
| Q1 2021 | -1.2% | -1.5% | -10.8% | |
| Q3 2020 | -3.3% | -10.4% | -0.8% | |
| Q2 2020 | -2.4% | -4.7% | -28.9% | |
| Q1 2020 | -45.7% | -49.0% | -6.0% | |
| Q4 2019 | -22.4% | -52.1% | -7.3% | |
| Q3 2019 | -5.8% | +6.3% | +2.9% | |
| Q2 2019 | -7.7% | -12.3% | -36.1% | |
| Q1 2019 | +2.5% | -8.4% | -13.9% | |
| Q4 2018 | -16.5% | -18.0% | -21.6% | |
| Q3 2018 | -9.3% | -9.3% | -27.9% | |
| Q2 2018 | +9.5% | +29.9% | +60.6% | |
| Q1 2018 | -2.4% | +1.1% | -13.1% | |
| Q4 2017 | -4.1% | -7.8% | -36.7% | |
| Q3 2017 | +0.0% | +0.0% | -25.0% | |
| Q2 2017 | -29.8% | -32.3% | -28.8% | |
| Q1 2017 | -3.8% | -3.0% | -3.8% | |
| Q4 2016 | -2.5% | -4.2% | +5.8% | |
| Q3 2016 | +20.8% | +20.1% | +18.8% | |
| Q2 2016 | +1.8% | +12.4% | +56.6% | |
| Q1 2016 | -12.3% | — | — | |
| Q4 2015 | -0.8% | — | — | |
| Q3 2015 | +8.5% | — | — | |
| Q2 2015 | +6.3% | — | — | |
| Q1 2015 | +1.0% | — | — | |
| Q4 2014 | -2.5% | — | — | |
| Q3 2014 | -3.3% | — | — | |
| Q2 2014 | +1.4% | — | — | |
| Q1 2014 | -0.8% | — | — | |
| Q4 2013 | +0.7% | — | — | |
| Q3 2013 | -11.8% | — | — | |
| Q2 2013 | -22.7% | — | — | |
| Q1 2013 | +3.5% | — | — | |
| Q4 2012 | +1.0% | — | — | |
| Q3 2012 | +10.6% | — | — | |
| Q2 2012 | -1.2% | — | — | |
| Q1 2011 | +0.8% | — | — | |
| Q1 2012 | +1.8% | — | — | |
| Q4 2011 | +0.5% | — | — | |
| Q4 2009 | +0.5% | — | — | |
| Q3 2011 | +4.9% | — | — | |
| Q3 2010 | +4.9% | — | — | |
| Q2 2010 | -10.2% | — | — | |
| Q4 2010 | -10.2% | — | — | |
| Q2 2011 | -10.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro